Aller au contenu principal
Profil bibliographique

Thomas Armstrong

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

39Publications signalées
1377Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Pancreatic and Hepatic Oncology ResearchHepatocellular Carcinoma Treatment and PrognosisPancreatitis Pathology and TreatmentCholangiocarcinoma and Gallbladder Cancer StudiesNeuroendocrine Tumor Research Advances

Les publications récentes

Accès ouvert 2023 article OpenAlex

Sub‐classification of laparoscopic left hepatectomy based on hierarchic interaction of tumor location and size with perioperative outcomes

Andrea Ruzzenente, Bernardo Dalla Valle, Edoardo Poletto, Nicholas Syn et autres

BACKGROUND: The aim of this multicentric study was to investigate the impact of tumor location and size on the difficulty of Laparoscopic-Left Hepatectomy (L-LH). METHODS: Patients who underwent L-LH performed across 46 centers from 2004 to 2020 were analyzed. Of 1236 L-LH, …

it, sg, jp, fr, kr, vn, br, de, no, cn, us, si, es, ru, gb, hk, be, tw, lb (code pays fourni par la source)

5 citations Journal of Hepato-Biliary-Pancreatic Sciences
Accès ouvert 2022 article OpenAlex

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

Paula Ghaneh, Daniel H. Palmer, Silvia Cicconi, Richard Jackson et autres

Background Patients with borderline resectable pancreatic ductal adenocarcinoma have relatively low resection rates and poor survival despite the use of adjuvant chemotherapy. The aim of our study was to establish the feasibility and efficacy of three different types of short-course neoadjuvant therapy …

gb, ch, de, us (code pays fourni par la source)

342 citations ˜The œLancet. Gastroenterology & hepatology
Accès ouvert 2022 article OpenAlex

Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines

Beth-Ann Coller, William Lapps, Mahum Yunus, Samantha Bruno et autres

This review describes key aspects of the development of the rVSVΔG-ZEBOV-GP Ebola vaccine and key activities which are continuing to further expand our knowledge of the product. Extensive partnerships and innovative approaches were used to address the various challenges encountered during this …

us (code pays fourni par la source)

15 citations Vaccines
Accès ouvert 2022 article OpenAlex

TH2.8 Continuing fast-track (Expedited) pancreaticoduodenectomy service during the Covid-19 pandemic: Experience from an established pancreatic surgical centre

Dharmadev Trivedi, Sheah Lin Lee, Arjun Takhar, Thomas Armstrong et autres

Abstract Aim Avoiding preoperative biliary drainage (PBD) can facilitate early curative surgery for patients with periampullary tumours. However, the evidence over PBD is conflicting. This prospective re-audit aimed to assess compliance to NICE guidelines (NG85) and surgical outcomes at a well-established HPB …

gb (code pays fourni par la source)

0 citations British journal of surgery
2021 article OpenAlex

P-P47 Impact of neoadjuvant chemotherapy on postoperative pancreatic fistula in patients undergoing pancreaticoduodenectomy

Lulu Tanno, Charlotte Davies, Claire Stevens, Richard Fristedt et autres

Abstract Background Pancreatic adenocarcinoma (PDAC) is one of the most lethal tumours with a five-year survival rate of less than 7% for all stages. However, current evidence suggests neoadjuvant treatment (NAT) may have survival benefits in those with borderline resectable disease. Post-operative …

gb (code pays fourni par la source)

0 citations British journal of surgery
Accès ouvert 2017 article OpenAlex

Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS)

Timothy H. Mungroop, L. Bengt van Rijssen, David van Klaveren, F. Jasmijn Smits et autres

OBJECTIVE: The aim of this study was to develop an alternative fistula risk score (a-FRS) for postoperative pancreatic fistula (POPF) after pancreatoduodenectomy, without blood loss as a predictor. BACKGROUND: Blood loss, one of the predictors of the original-FRS, was not a significant …

nl, it, us, gb, de, kh (code pays fourni par la source)

416 citations Annals of Surgery

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.